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RESUMO.- [Expressão e distribuição da conexina 32
em fígados de ratos com fibrose induzida experimen-
talmente.] A conexina 32 (Cx32) é uma proteína que cons-
titui os canais que promovem as comunicações intercelu-
lares via junções comunicantes (CIJC) no fígado, permi-
tindo difusão de pequenas moléculas citoplasmáticas de
uma célula à outra. A fibrose hepática caracteriza-se pela
alteração da arquitetura normal do fígado e podem alterar
as CIJCs. O objetivo deste trabalho foi estudar a expres-
são e distribuição de Cx32 na fibrose hepática. O objetivo
do presente trabalho foi estudar a expressão e distribui-
ção da Cx32 em fígados com fibrose induzida pela admi-
nistração oral de dimetilnitrosamina em fêmeas de ratos
Wistar. A necropsia foi realizada após cinco semanas da
última administração da droga e observou-se um quadro
de fibrose hepática. Amostras dos fígados com fibrose e
de animais controle foram submetidas à análise imunois-
toquímica, por Real Time-PCR e por Western-Blot verifi-
cando-se a presença de Cx32 difusa e dispersa no cito-
plasma dos fígados com fibrose. No grupo controle a Cx32
localizou-se na membrana citoplasmática com a forma-
ção de placas juncionais. O fígado com fibrose também
revelou diminuição da expressão gênica de Cx32, embo-
ra sem a redução da quantidade do produto protéico, quan-
do comparado ao grupo controle. Estes resultados suge-
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The connexin 32 (Cx32) is a protein that forms the channels that promote the gap
junction intercellular communication (GJIC) in the liver, allowing the diffusion of small
molecules through cytosol from cell-to-cell. Hepatic fibrosis is characterized by a disruption
of normal tissue architeture by cellular lesions, and may alter the GJIC. This work aimed
to study the expression and distribution of Cx32 in liver fibrosis induced by the oral
administration of dimethylnitrosamine in female Wistar rats. The necropsy of the rats
was carried out after five weeks of drug administration. They presented a hepatic fibrosis
state. Sections from livers with fibrosis and from control livers were submitted to
immunohistochemical, Real Time-PCR and Western-Blot analysis to Cx32. In fibrotic
livers the Cxs were diffusely scattered in the cytoplasm, contrasting with the control
livers, where the Cx32 formed junction plaques at the cell membrane. Also it was found
a decrease in the gene expression of Cx32 without reduction in the protein quantity when
compared with controls. These results suggest that there the mechanism of intercellular
communication between hepatocytes was reduced by the fibrotic process, which may
predispose to the occurrence of a neoplastic process, taken in account that connexins
are considered tumor suppressing genes.
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rem que o mecanismo de comunicação intercelular entre
os hepatócitos reduziu-se durante o processo fibrótico, o
que pode predispor a ocorrência de processos neoplási-
cos, uma vez que as conexinas são consideradas genes
supressores de tumores.
TERMOS DE INDEXAÇÃO: Dimetilnitrosamina, fibrose, fíga-
do, Cx32, junção comunicante.
INTRODUCTION
Liver fibrosis occurs as a result of toxic lesions and
inflammation of the liver, and may have several causes.
The difference between liver fibrosis and other histo-
pathological conditions of the liver is the fact that fibrosis
is usually a progressive lesion that changes the hepatic
architecture and function. This pathological process is
called cirrhosis (Johnson 2000, Crawford 2005), which may
favor more severe morphological changes, such as a
cancer. In dogs, fibrosis is a consequence of chonic
hepatitis and often progresses to cirrhosis (Watson 2004).
Hepatocytes, like any cell of multicellular organisms, need
to be in contact with other cells. Among the several cell-to-
cell contact points, gap junctions are structures that allow
cytosolic communication between adjacent cells and direct
exchanging of small molecules (Saez et al. 1989). Gap
junctions which play a very important role in maintaining tissue
homeostasis and control of cell differentiation and proliferation
(Yamasaki 1991). They are formed by transmembrane
channels called connexons that are composed by protein
subunits called connexins (Cxs). Hepatocytes gap junctions
are constituted by two predominant types of connexins: Cx32
and Cs26 (Zhang & Nicholson 1989). Gap junctions allow
ions and small molecules that regulate cell proliferation to
enter the cytoplasm, thus being directly involved in
homeostasis control, preventing a neoplastic alteration
(Yamasaki 1991). This has been confirmed in seven types
of human hepatocellular carcinomas, where considerable
less, quantity of connexins per square millimeter is found
when compared with non-carcinomatous cirrhotic tissues
(Yamaoka 1995). Connexin 32 expression seems to be im-
portante in liver disease progression to spontaneous or
chemichally induced liver tumors (Temme et al. 1997,
Moennikes et al. 1999).
Fibrosis is a state that precedes cirrhosis (Friedman
1993, Pines et al. 1997, Paradis et al. 1999, Yasuda et al.
1999, Lee et al. 2004, Crawford 2005) and is secondary to
severe hepatic lesions and may significantly contribute to
the disease and death (Cheville 1999). Cxs32 show an
important correlation with cirrhosis and tumors. Here we
studied the expression and location of connexin 32 (Cx32)
during chemically induced fibrosis to verify how these
characteristics are affected in the fibrosis process.
MATERIALS AND METHODS
Animals and experimental design
Thirty-month-old female Wistar rats weighing 220 ±10g were
employed in this study. They were fed with standard rat diet and
water ad libitum and housed in cages with controlled temperature
and humidity. Rats were provided by the animal facility of the
Department of Pathology of the School of Veterinary Medicine,
University of São Paulo. All rats received human care according
to the criteria outlined in the ‘Guide for the Care and Use of
Laboratory Animals’ and the experimental procedure was
approved by the institutional Bioethics Committee (protocol
number 1046/2007). Fibrosis was induced by gastric gavage
with an aqueous solution of dimethylnitrosamine (DMN, Sigma-
Aldrich, St Louis, Missouri, USA) during five weeks, twice a week
(10mg/kg), followed by a resting period of four weeks. Rats were
identified and distributed into 2 groups of 15 animals each and
classified as group 1D and group 2C. Group 1D comprised
animals that were given dimethylnitrosamine (DMN). After this
period, the animals were observed for five weeks and than were
euthanized. Animals of group 2C (control group), which did not
receive dimethylnitrosamine (DMN), were euthanized together
with group 1D animals.
Histology and immunohistochemistry procedure
Fragments from each liver were fixed in Bouin fixative for 12
hours, embedded in paraffin wax, and 5 μm tissue sections were
stained with hematoxylin-eosin, picrosirius-hematoxylin and
picrosirius alone for a histopathologic examination by a veterinary
pathologist. Liver samples were stored in liquid nitrogen for Real
Time-PCR (Real Time Polymerase Chain Reaction), Western-
Blot and immunohistochemistry analyses. Frozen tissue samples
were cut in cryostat (7 mm), ixed in metacarn for 10 minutes
and used for identification of the Cx32. The sections were
incubated overnight with rabbit anti-connexin 32 polyclonal
antibodies (Zymed®, South San Francisco, USA) diluted 1:500
in PBS (Phosphate Buffer Solution) followed by biotinylated goat
anti-rabbit secondary antibody (Dako®, Carpinteria, USA) diluted
1:300 in PBS for one hour. In the next step, the slides were
incubated by 30 minutes with 1:100 streptavidin-peroxidase and
visualized by. tyramide-fluorescein from TSA Fluorescence Kit
visualization system (PerkinElmer Life Science Inc®, Boston
USA). Nuclei were counterstained with propidium iodide
(Sigma®, St Louis, USA) at a concentration of 10 mg/ml. The
slides were mounted with Prolong Gold Antifade Reagent
(Invitrogen, Carlsbad USA) permanent mounting media.
Western-blot
After cell lysis of the hepatic tissue (40mg), 150mg of protein
lysate to which  bromophenol blue was added were subjected
to sodium dodecyl sulfate polyacrylamide gel electrophoresis
on 10% acrylamide gels with 10ml of Kaleidoscope Prestained
Standard (Bio-Rad Labs®, California, USA) as molecular weight
marker..The proteins were transferred to a PDVF (Polyvinylidene
Fluoride) 8.0 x 5.0cm2 membrane (Trans-Blot SD cell; Bio-Rad
Labs®, California, USA) and incubated for 1 hour in 5% skim
milk in 7.2 M PBS followed overnight  incubation with rabbit
anti-Cx32 polyclonal antibody (Zymed)  diluted 1:100 in PBS.
The blot was washed in PBS and incubated for 1 hour with goat
anti-rabbit peroxidase-conjugated antibody (Zymed) diluted
1:1000 in PBS. The bands were visualized with a solution
containing diaminobenzidine (DAB)-nickel in PBS to which 20
μl of hydrogen peroxide at 30% were added.
mRNA quantification by RT-PCR
Total RNA was extracted using Trizol Reagent (Invitrogen
Life Technologies, Carlsbad, CA, USA) according to
manufacturer’s instructions. RNA integrity check was run in 1.5%
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agarose gel. RNA quantification was carried out by the
Biophotometer (EppendorfÒ, USA). Total RNA was treated with
DNAse I (Invitrogen) in order to remove all remaining DNA. After
cDNA construction, quantitative real-time PCR was carried ou
with the ABI PRISM 7000 Sequence Detection System (Applied
Biosystem, Foster City, California) using TaqMan Universal
Master Mix (Applied Biosystems) for detection of Cx32 and beta-
actin (housekeeping gene) gene expression.
The primers and probes specific for Cx32 and beta-actin
were selected with the Primer Express software programs
(Applied Biosystems). The Cx32 forward primer 5´-
GGGTGGCCTCAAGGATAG-3´ and the reverse primer 5´-
ATGAACTGGACAGGTCTATACACC-3´ were chosen to amplify
a 69-bp fragment. The internal Cx32 TaqMan probe used was
FAM-5’- CTCCCCAGGTGTGAATG -3’NFQ. The beta-actin
primers, 5’-AGATTACTGCCCTGGCTCCTA-3´ (forward primer,
82 bp), the reverse primer 5´-CAAGTACTCTGTGTG-
GATTGGTGG-3´ and the TaqMan probe (VIC-5’-
ACCATGAAGATCAAGATCAT-3’-MGBNFQ were used as
housekeeping control. The internal Cx32 and beta-actin TaqMan
probes were designed following the manufacturer´s general
rules. The analysis of relative gene expression was performed
according to the 2-DDCT method (Livak & Schmittgen 2001).
RESULTS
Liver fibrosis was found in all animals treated with DMN,
with the presence of the following lesions: regenerative
nodules, fibrosis and fibrotic bridges, inflammatory infiltrate
with oval cells proliferation, bile ducts proliferation and
megalocytosis. Immunohistochemical analysis showed
that the Cxs32 was located at the hepatocyte cell
membrane in rats of the control group (group 2C), forming
fluorescent spots that characterize the gap junctions. The
cytoplasm also showed light and difuse staining (Fig.1a).
In DMN-treated animals the Cx32 proteins, the Cxs32 was
mainly concentrated in the hepatocyte cytoplasm, around
the nuclei (Fig.1b).
The mRNA Cx32 level in liver with fibrosis was 40%
lower than in the liver of the rats from the control group
when the data was normalized with the level of mRNA
expression of the constitutive gene beta-actin Amplification
peak means were 0.66 for animals treated and 1.16 for
non-treated animals (Table 1).  The analysis resulting from
Western-blot method showed that the Cxs32 in liver tissues
did not present any differences in terms of size of protein
products between the animals treated with DMN and the
ones that were not treated (Fig.2).
DISCUSSION
We used DMN as fibrosis-inducing drug because it is a
potent hepatotoxic agent (Barnes & Magee 1954), because
of its total metabolization in the liver and because it can
reproduce fibrosis in a most accurate way in animals and
humans (Magee 1956 1958). The immunohistochemical
technique showed that Cx32 was located in the cell
membrane forming junction plaques in control animals, a
fact that was expected, since Cxs are the proteins
responsible for forming gap junctions between neighboring
cells. In contrast, after treatment with DMN, the Cxs32
appeared rather diffusely scattered in the cytoplasm.
Recently, in vitro studies verified that Cxs32 can be
expressed without forming gap junctions, being accu-
mulated in the cytoplasm, if their intracellular transport
mechanism is deficient (Hernandez-Blázquez et al. 2001)
or in the absence of E-cadherin (Yano et al. 2001). That
could explain the atypical plaques and the increase of
mRNA without increase of gap junctions described by
Nakata et al. (1996). The reason for this difference in
location is not clear, but it may be due to the fact that in
the liver, post-lesion regenerative processes multiply and
decrease intercellular communication mediated by gap
junctions.
Fig.2. Western blot of hepatic tissue for Cx32 of the rats treated
and not treated with DMN. 1 to 3: Control rats not treated
with DMN; 4 to 7: Rats treated with DMN and that developed
fibrosis; MW: Molecular weight marker. The weight of the
molecular marker is indicated at the right of the figure.
Table 1. Levels of normalized connexin32 mRNA in livers
of rats treated or not treated with DMN measured by
quantitative Real Time-PCR
Groups Difference in cycles between Normalized Cx32
(N=6) Cx32 and ß-actin “CT amount 2-””CT
Treated 9.66 ± 0.9 0.66 ±  0.3*
Not treated 8.86 ± 0.5 1.16 ± 0.3**
The means in the same column followed by asterisk (*) were significantly
different under Student t test (p<0.05).
Fig.1. Photomicrographs of histological sections of the liver of
animals from (a) Group 2C (control group), showing positive
reaction for Cx32 (arrows) in cell membranes of hepatocytes,
and (b) the Cx32 forming intracytoplasm aggregates (arrows)
in hepatocytes of fibrotic liver. The nuclei were stained light
grey (using propidium iodate) for background contrast. Bar
= 50μm.
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With regard to the results obtained from molecular
analyses, we observed a 40% decrease in gene expression
for Cx32 in animals treated with DMN using Real Time -
PCR technique. This decrease in gene expression of Cx32
may be due to up-down regulation mechanisms or negative
regulation, which is caused by the organism itself in an
attempt of recover homeostasis.
In order to discover if the gene expression for Cx32
was accompanied by decrease in the quantity of protein
present in cells, the western-blot technique was used.
However, there were no differences between animals
treated with DMN (rats with liver fibrosis) and animals not
treated in what relates to the amount of the protein product.
This may indicate that the translation system is in principle
intact, and that the treatment did not suffice for promoting
significant changes. With respect to the quantity of Cx32
available for the cell, no reduction in the quantity of protein
product in rats with fibrosis was observed, which indicates
that reduction in the quantity of Cx32 mRNA in liver fibrosis
is not accompanied by reduction in protein product quantity.
A hypothesis to explain this fact may come from the finding
that in control animals Cxs were in the membrane, whereas
in treated animals they were in the cytoplasm. The Cxs
present in cytoplasm that did not form gap junctions have
a prolonged half-life, as demonstrated by Hernandez-
Blazquez et al. (2001) in cells treated with cycloheximide,
a protein synthesis inhibitor. After 48 hours of protein
synthesis blockade, Cxs of the types 43 and 26 were still
present in the cytoplasm and were able to form functional
channels when stimulated by the addition of calcium.
However, some works show that the half-lives of Cxs
present in junctions can last 1-3 hours (Traub et al. 1989,
Laird et al. 1991). It is possible that the reduced transit of
Cxs to the cell membranes can cause Cxs with prolonged
half-lives to build up in the cytoplasm. This excess of
unused Cxs with prolonged half-lives might explain why
the general quantity of protein does not change, even with
a reduction of the mRNA available for protein synthesis.
This hypothesis is supported by the observation described
in other models, whose cells keep a cytoplasm population
of Cxs on standby in their cytoplasm (Laird et al. 1995,
Hernandez-Blazquez et al. 2001, Yano et al. 2001).
Interestingly, two bands of Cx protein may be observed in
the western-blot membrane, around the 32 kDa region,
suggesting that the heavier top band is the phosphorilated
form of Cx32 and the lower band is the non-phosphorilated
form and they coexist both in the fibrosis or normal state
of the liver. Due to the importance of Cx32 for forming gap
junctions in hepatic cells, we may assume that there was
a decline in cellular communication processes, since the
presence of these Cxs decreased in cellular membranes
and increased in cytoplasm. In view of the fact that the
gene of Cx32 is considered to be a tumor suppressor gene
for liver tumors (Neveul et al. 1994), the reduction of its
expression in fibrosis can favor the development of cells
initiated in the process of malignant transformation.
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